Go to deals
Consumer & Retail | Food & Beverage | Healthcare | TMT

Qilibri has been acquired by SP2L (NaturAvignon Laboratory)

The owners of Qilibri, which include the co-founders, Day One Entrepreneurs & Partners, Pléiade Venture and Financière Saint-James, and business angels, have sold the company to SP2L (NaturAvignon Laboratory).

Qilibri is a French digital-native brand founded in 2019 by two experienced entrepreneurs, offering a holistic approach to weight loss through healthy pre-cooked meals delivery, professional dietary assistance and sports training. Qilibri uses algorithms to determine customers’ needs in order to maximize weight loss and lasting results, compared with standard offers. Qilibri’s objective is to redesign weight loss with a 360° offer based on a 100% customized program, which includes a qualitative nutrition offer designed by expert dieticians and a complete service offer via weekly professional dietary coaching, access to an online community and sport training, in partnership with a leading fitness club operator. Qilibri’s innovative, fully customized and efficient offer has enabled the company to quickly develop a community of approximately 200,000 people. Today, Qilibri is a brand recognized for its ability to leverage customers’ data, enabling to build a personalized and qualitative relationship throughout the program.

Founded in 2003, Groupe SP2L (Laboratoire NaturAvignon) offers safe, effective dietary supplements, health products and professional support to help seniors improve their health. Groupe SP2L comprises two brands: Laboratoire NaturAvignon, an emblematic brand in nutraceuticals for 20 years, and Blanche Bresson Institut, a digital brand of natural and organic food supplements.

Oaklins’ team in France acted as sell-side M&A advisor in the transaction.

Parties

Talk to the deal team

Antoine Lemaire

Partner
Paris, France
Oaklins France

Charlotte Delphis

Associate Director
Paris, France
Oaklins France

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more